Education
Ph.D. in Cell & Develop Biology, Oregon Health & Science University, 2012
Current position
Postdoctoral Researcher, Molecular Genetics, University of Oregon
Publications
Research papers
-
Bicocca, V. T., Chang, B. H., Masouleh, B. K., Muschen, M., Loriaux, M. M., Druker, B. J. and Tyner, J. W. (2012). Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia. Cancer Cell 22(5): 656-667.
-
Tomilov, A. A., Bicocca, V., Schoenfeld, R. A., Giorgio, M., Migliaccio, E., Ramsey, J. J., Hagopian, K., Pelicci, P. G. and Cortopassi, G. A. (2010). Decreased superoxide production in macrophages of long-lived p66Shc knock-out mice. J Biol Chem 285(2): 1153-1165.
-
Spence, K. O., Bicocca, V. T. and Rosenheim, J. A. (2007). Friend or foe?: a plant's induced response to an omnivore. Environ Entomol 36(3): 623-630.
-
Stork, J. R., Rios, D., Pham, D., Bicocca, V., Olmstead, M. M. and Balch, A. L. (2005). Metal-metal interactions in platinum(II)/gold(I) or platinum(II)/silver(I) salts containing planar cations and linear anions. Inorg Chem 44(10): 3466-3472.
Abstracts
-
Bicocca, V.T., Chang, B.H., Muschen, M., Loriaux, M.M., Druker, B.J., and J.W. Tyner. (2011). Compensatory Signaling from ROR1 and the Pre-B Cell Receptor Promote Survival of t(1;19) Acute Lymphoblastic Leukemia. Abstract in Blood 118 (21): 1057.
-
Bicocca, V.T., Chang, B.H., Muschen, M., Loriaux, M.M., Druker, B.J., and J.W. Tyner. (2010). ROR1 as a Therapeutic Target in E2A-PBX1-Positive Acute Lymphoblastic Leukemia. Abstract in Blood 116 (21): 240.
-
Tyner, J.W., Loriaux, M.M., Willis, S.G., Chang, B.H., Bicocca, V., Oh,
S., Hollink, I., Segers, S., den Boer, M., Heuvel-Eibrink, M., Zwaan,
C.M., Gotlib, J.R. Deininger, M.W., and B.J. Druker. (2009). RAPID siRNA Screen for Identification of Therapeutic Gene Targets in Patients with Hematologic Malignancies. Abstract in Blood, 114 (22): 1529.
-
Tyner, J.W., Loriaux, M.M., Willis, S.G., Chang, B.H., Bicocca, V., Oh,
S., Hollink, I., Segers, S., den Boer, M., Zwaan, C.M., Gotlib, J.R.
Deininger, M.W., and B.J. Druker. (2008). RNAi Screening of the Tyrosine Kinome Identifies Therapeutic Targets in Leukemia Patients. Abstract in Blood, 112 (11): 281.
-
O'Hare, T., Mousses, S., Shanmugam, K., Bicocca, V. T., Eide, C. A., Jacob, J., Williamson, T., Shannon, P., MacArthur, R. B. and Weitman, S. (2007). A new class of thienopyrimidine Src inhibitors demonstrates potent growth suppression of imatinib resistant Ba/F3 cells harboring a wide range of BCR-ABL mutations, including the CML relevant T315I. AACR Meeting Abstract, B238.